FDA Adverse Event Injury Summary report: N

UNK MAMMARY IMPLANT

MDR report key: 11641609 · Received April 9, 2021

Report

Report Number
9617229-2021-06055
Event Type
Injury
Date Received
April 9, 2021
Date of Event
January 5, 2021
Report Date
April 9, 2021
Manufacturer
UNKNOWN MANUFACTURER
Product Code
FWM
PMA / PMN Number
P990074
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ARTICLE CITATION: QUESADA, ANDRES E., ZHANG, YANMING, PTASHKIN, RYAN, ET AL. NEXT GENERATION SEQUENCING OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAS REVEALS A NOVEL STAT3-JAK2 FUSION AMONG OTHER ACTIVATING GENETIC ALTERATIONS WITHIN THE JAK-STAT PATHWAY. THE BREAST JOURNAL. 05/JAN/2021; 1-8. THE EVENT OF LYMPHOMA - ALCL IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: BIA-ALCL.

Description of Event or Problem · 1

THROUGH JOURNAL ARTICLE ¿NEXT GENERATION SEQUENCING OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAS REVEALS A NOVEL STAT3-JAK2 FUSION AMONG OTHER ACTIVATING GENETIC ALTERATIONS WITHIN THE JAK-STAT PATHWAY,¿ AUTHORS REPORT A 66 YEAR OLD PATIENT AND REASON FOR IMPLANT IS NOTED AS INVASIVE DUCTAL CARCINOMA. PATIENT WAS IMPLANTED WITH A TEXTURED IMPLANT OF AN UNKNOWN FILL AND PRESENTED WITH A CUTANEOUS LESION ELEVEN YEARS AFTER IMPLANT. THE STAGE OF ALCL WAS NOTED AS T4. TREATMENT PROVIDED AS XRT, 6 CYCLES BV-CHOP, AND STEM CELL TRANSPLANT. THE MANUFACTURER OF THE DEVICE IS UNKNOWN. AFFECTED SIDE IS UNKNOWN. THE STATUS OF THE DEVICE IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
539300 UNK MAMMARY IMPLANT PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE FWM UNKNOWN MANUFACTURER NI

Patients

Seq Age Sex Outcome Treatment
1 66 YR Life Threatening| R